4/A
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-23-033419
Chief Financial Officer sold 2,012 shares at $11.16 ($22,454)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2023-04-28 | Sale | −2,012 | $11.16 | $22,454 | 148,123 | D |
| Open-market sales · 2,012 sh · avg $11.16 · $22,454 | |||||||
Loading xslF345X04/doc4a.xml…